Key facts
- This page summarizes James F. Polewaczyk's Form 4 filing for IDEXX LABORATORIES INC /DE (IDXX).
- 11 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 07 Mar 2024, 17:00.
James F. Polewaczyk - 06 Mar 2024 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)
- Reporting relationship
- Executive Vice President
- Issuer ticker
- IDXX
- Reported as of
- 06 Mar 2024
- Net transaction value
- -$1,102,049
- SEC form
- 4
- Accepted by SEC
- 07 Mar 2024, 17:00:38 UTC
- Prior SEC filing
- 16 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Lily J. Lu, Attorney-in-Fact for James F. Polewaczyk
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
James F. Polewaczyk filed Form 4 for IDEXX LABORATORIES INC /DE (IDXX) on 07 Mar 2024.
Change
- Previous filing in this sequence was filed on 16 Feb 2024.
- Current net transaction value: -$1,102,049.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IDXX
transaction
Common Stock
Options Exercise
- Transaction value
- $156,240
- Shares
- +755
- Change %
- +7%
- Price
- $206.94
- Shares after
- 11,466
- Date
- 06 Mar 2024
- Ownership
- Direct
IDXX
transaction
Common Stock
Options Exercise
- Transaction value
- $99,952
- Shares
- +483
- Change %
- +4.2%
- Price
- $206.94
- Shares after
- 11,949
- Date
- 06 Mar 2024
- Ownership
- Direct
IDXX
transaction
Common Stock
Options Exercise
- Transaction value
- $642,824
- Shares
- +2,226
- Change %
- +19%
- Price
- $288.78
- Shares after
- 14,175
- Date
- 06 Mar 2024
- Ownership
- Direct
IDXX
transaction
Common Stock
Options Exercise
- Transaction value
- $2,524,531
- Shares
- +4,640
- Change %
- +33%
- Price
- $544.08
- Shares after
- 18,815
- Date
- 06 Mar 2024
- Ownership
- Direct
IDXX
transaction
Common Stock
Sale
- Transaction value
- $2,306,528
- Shares
- -4,134
- Change %
- -22%
- Price
- $557.94
- Shares after
- 14,681
- Date
- 06 Mar 2024
- Ownership
- Direct
- Footnotes
- F1
IDXX
transaction
Common Stock
Sale
- Transaction value
- $1,838,722
- Shares
- -3,290
- Change %
- -22%
- Price
- $558.88
- Shares after
- 11,391
- Date
- 06 Mar 2024
- Ownership
- Direct
- Footnotes
- F2
IDXX
transaction
Common Stock
Sale
- Transaction value
- $380,346
- Shares
- -680
- Change %
- -6%
- Price
- $559.33
- Shares after
- 10,711
- Date
- 06 Mar 2024
- Ownership
- Direct
- Footnotes
- F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IDXX
transaction
Derivative
Non-Qualified Stock Option (right-to-buy)
Options Exercise
- Transaction value
- $0
- Shares
- -755
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 06 Mar 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 755
- Exercise price
- $206.94
- Footnotes
- F4
IDXX
transaction
Derivative
Incentive Stock Option (right-to-buy)
Options Exercise
- Transaction value
- $0
- Shares
- -483
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 06 Mar 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 483
- Exercise price
- $206.94
- Footnotes
- F5
IDXX
transaction
Derivative
Non-Qualified Stock Option (right-to-buy)
Options Exercise
- Transaction value
- $0
- Shares
- -2,226
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 06 Mar 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,226
- Exercise price
- $288.78
- Footnotes
- F6
IDXX
transaction
Derivative
Non-Qualified Stock Option (right-to-buy)
Options Exercise
- Transaction value
- $0
- Shares
- -4,640
- Change %
- -77%
- Price
- $0.000000
- Shares after
- 1,363
- Date
- 06 Mar 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,640
- Exercise price
- $544.08
- Footnotes
- F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
Represents the weighted average price of the shares sold ranging from a low of $557.33 to a high of $558.32 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Footnote F2
Represents the weighted average price of the shares sold ranging from a low of $558.45 to a high of $559.29 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Footnote F3
Represents the weighted average price of the shares sold ranging from a low of $559.51 to a high of $559.74 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Footnote F4
Grant of option to buy 5,711 shares of Issuer common stock that vest in five annual installments beginning February 14, 2020.
Footnote F5
Grant of option to buy shares of Issuer common stock that vested in one installment on February 14, 2024.
Footnote F6
Grant of option to buy 8,906 shares of Issuer common stock that vest in four annual installments beginning February 14, 2021.
Footnote F7
Grant of option to buy 6,003 shares of Issuer common stock that vest in four annual installments beginning February 14, 2022.